My background is in US Securities and I'm not that familiar with Canadian regulations, but, from what I can tell, it eases reporting requirements for issuing new stock for companies that qualify. Before a company can issue new shares to the public, it has to file a prospectus. This allows InMed to use what might be described as a summary prospectus. It doesn't require that they issue any new stock but...